ClinicalTrials.gov
public full text
Public Domain
The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine
An open-label, single-arm and multi-center study for 16 weeks
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Switching to Iloperidone From Other Antipsychotics in Schizophrenia#840027
- A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.#1196567
- Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"#877306
- Clinical Trial of Dipyridamole in Schizophrenia#877444
- Evaluation of Mirtazapine and Folic Acid for Schizophrenia:#803081
Record · ID 1409768
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive